Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/oFSAnhgXxzQ   Vaccination with the Moderna mRNA CoVid vaccine is significantly more likely to induce production of protective antibodies in breast milk than either the Pfizer or the Johnson and Johnson vaccines.  Infectious disease researchers at New York’s Mt. Sinai Hospital report these results after studying the levels of anti-CoVid antibodies in the breast milk of 50 women before and after vaccination.    In terms of IgA levels, 93% of Moderna recipients developed significant levels compared with 74% of those getting Pfizer and 54% of those receiving J&J.  For secretory antibodies, 86% for Moderna vs. 61% for either Pfizer or J&J.  For IgG, 100% of those receiving either the Moderna or Pfizer had a significant increase versus only 62% for J&J.   Since anti-CoVid vaccines have not yet been approved for infants and children under 12, this study suggests that breastmilk from Moderna-vaccinated mothers is most likely to passively transfer CoVid immunity.    https://ww